Is Novozymes (NVZMY) Stock Outpacing Its Basic Materials Peers This Year?
Werte in diesem Artikel
For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Novozymes A/S (NVZMY) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector should help us answer this question.Novozymes A/S is one of 232 companies in the Basic Materials group. The Basic Materials group currently sits at #7 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Novozymes A/S is currently sporting a Zacks Rank of #1 (Strong Buy).The Zacks Consensus Estimate for NVZMY's full-year earnings has moved 9% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.Our latest available data shows that NVZMY has returned about 17.3% since the start of the calendar year. At the same time, Basic Materials stocks have gained an average of 4.6%. This shows that Novozymes A/S is outperforming its peers so far this year.Another stock in the Basic Materials sector, Mosaic (MOS), has outperformed the sector so far this year. The stock's year-to-date return is 37%.Over the past three months, Mosaic's consensus EPS estimate for the current year has increased 19.4%. The stock currently has a Zacks Rank #2 (Buy).Breaking things down more, Novozymes A/S is a member of the Chemical - Specialty industry, which includes 37 individual companies and currently sits at #144 in the Zacks Industry Rank. This group has gained an average of 0.9% so far this year, so NVZMY is performing better in this area.Mosaic, however, belongs to the Fertilizers industry. Currently, this 7-stock industry is ranked #21. The industry has moved +21.6% so far this year.Investors interested in the Basic Materials sector may want to keep a close eye on Novozymes A/S and Mosaic as they attempt to continue their solid performance.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novozymes A/S (NVZMY): Free Stock Analysis Report The Mosaic Company (MOS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Novozymes A-S (B)
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Novozymes A-S (B)
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Novozymes A-S (B)
Analysen zu Novozymes A-S (B)
Datum | Rating | Analyst | |
---|---|---|---|
17.10.2012 | Novozymes hold | Deutsche Bank AG | |
03.09.2012 | Novozymes buy | ING | |
28.08.2012 | Novozymes overweight | Morgan Stanley | |
09.08.2012 | Novozymes overweight | Morgan Stanley | |
22.06.2012 | Novozymes overweight | Morgan Stanley |
Datum | Rating | Analyst | |
---|---|---|---|
03.09.2012 | Novozymes buy | ING | |
28.08.2012 | Novozymes overweight | Morgan Stanley | |
09.08.2012 | Novozymes overweight | Morgan Stanley | |
22.06.2012 | Novozymes overweight | Morgan Stanley | |
17.11.2011 | Novozymes overweight | Morgan Stanley |
Datum | Rating | Analyst | |
---|---|---|---|
17.10.2012 | Novozymes hold | Deutsche Bank AG | |
15.10.2010 | Novozymes hold | Vontobel Research | |
13.08.2010 | Novozymes hold | Vontobel Research |
Datum | Rating | Analyst | |
---|---|---|---|
05.05.2005 | Novozymes: Sector Underperform | Vontobel |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Novozymes A-S (B) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen